Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-09 09:02 am Sale | 2024-09-30 | 13G | VOLCON INC PAR $0.00001 NE EMPD | Empery Asset Management, LP | 52,162 0.980% | -21,027,967 (-99.75%) | Filing History |
| 2024-10-09 09:01 am Unchanged | 2024-09-30 | 13G | ELEVATION ONCOLOGY INC ELEV | Empery Asset Management, LP | 4,000,000 4.990% | 0 (Unchanged) | Filing History |
| 2024-10-09 09:01 am Purchase | 2024-09-30 | 13G | SHARPS TECHNOLOGY INC STSS | Empery Asset Management, LP | 539 4.990% | 531 (+6637.50%) | Filing History |
| 2024-10-09 09:00 am Purchase | 2024-09-30 | 13G | SOBR SAFE INC PAR $0.001 SOBR | Empery Asset Management, LP | 57,093 1.620% | 56,001 (+5128.30%) | Filing History |
| 2024-01-23 12:51 pm Unchanged | 2023-12-31 | 13G | CYNGN INC CYN | Empery Asset Management, LP | 373 4.990% | 0 (Unchanged) | Filing History |
| 2024-01-11 4:53 pm Purchase | 2023-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Empery Asset Management, LP | 17,399 9.990% | 17,399 (New Position) | Filing History |
| 2024-01-11 3:55 pm Purchase | 2023-12-31 | 13G | VOLCON INC EMPD | Empery Asset Management, LP | 21,080,129 9.990% | 9,002,834 (+74.54%) | Filing History |
| 2024-01-10 09:00 am Purchase | 2023-12-31 | 13G | CYNGN INC CYN | Empery Asset Management, LP | 373 9.990% | 19 (+5.37%) | Filing History |
| 2024-01-09 09:07 am Purchase | 2023-12-31 | 13G | ELEVATION ONCOLOGY INC ELEV | Empery Asset Management, LP | 4,000,000 6.700% | 4,000,000 (New Position) | Filing History |
| 2024-01-09 09:06 am Purchase | 2023-12-31 | 13G | CYNGN INC CYN | Empery Asset Management, LP | 354 9.990% | 354 (New Position) | Filing History |
| 2024-01-09 09:05 am Purchase | 2023-12-31 | 13G | SOBR SAFE INC SOBR | Empery Asset Management, LP | 1,092 6.090% | 1,092 (New Position) | Filing History |
| 2024-01-09 09:03 am Purchase | 2023-12-31 | 13G | NUVVE HOLDING CORP. COM NVVE | Empery Asset Management, LP | 16 9.990% | 16 (New Position) | Filing History |
| 2024-01-08 10:26 am Sale | 2023-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | Empery Asset Management, LP | 151,654 2.650% | -54,969 (-26.60%) | Filing History |
| 2024-01-08 10:25 am Sale | 2023-12-31 | 13G | KIROMIC BIOPHARMA INC KRBPQ | Empery Asset Management, LP | 0 0.000% | -163,268 (Position Closed) | Filing History |
| 2024-01-08 10:23 am Purchase | 2023-12-31 | 13G | REDHILL BIOPHARMA LTD RDHL | Empery Asset Management, LP | 10,365,184 3.190% | 10,210,184 (+6587.22%) | Filing History |
| 2024-01-08 10:22 am Unchanged | 2023-12-31 | 13G | PERMEX PETE CORP OILCF | Empery Asset Management, LP | 52,083 4.990% | 0 (Unchanged) | Filing History |
| 2023-01-13 08:04 am Purchase | 2022-12-31 | 13G | REDHILL BIOPHARMA LTD RDHL | Empery Asset Management, LP | 155,000 6.120% | 155,000 (New Position) | Filing History |
| 2023-01-13 08:02 am Purchase | 2022-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | Empery Asset Management, LP | 206,623 5.120% | 206,623 (New Position) | Filing History |
| 2023-01-13 08:00 am Purchase | 2022-12-31 | 13G | VOLCON INC EMPD | Empery Asset Management, LP | 12,077,295 9.990% | 12,077,295 (New Position) | Filing History |
| 2023-01-12 10:03 am Purchase | 2022-12-31 | 13G | PERMEX PETE CORP COM OILCF | Empery Asset Management, LP | 52,083 9.580% | 52,083 (New Position) | Filing History |